Dashboard Tools Market News Investing Ideas Pricing
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
Pro Medicus Ltd banner

Pro Medicus Ltd
ASX:PME

Watchlist Manager
Pro Medicus Ltd Logo
Pro Medicus Ltd
ASX:PME
Watchlist
Price: 193.1 AUD 0.25% Market Closed
Market Cap: AU$20.2B
Write Note Create Alert Ask AI

Wall St Price Targets

PME Price Targets Summary
Pro Medicus Ltd

Wall Street analysts forecast PME stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PME is 193.26 AUD with a low forecast of 111.1 AUD and a high forecast of 257.25 AUD.

PME Lowest Forecast
111.1 AUD
-42% Downside
PME Average Forecast
193.26 AUD
0% Upside
PME Highest Forecast
257.25 AUD
33% Upside
Lowest Forecast
Price Target
111.1 AUD
42% Downside
Average Forecast
Price Target
193.26 AUD
0% Upside
Highest Forecast
Price Target
257.25 AUD
33% Upside
Pro Medicus Ltd Competitors:
Price Targets
TDOC
Teladoc Health Inc
-24% Downside
WHF
WhiteHorse Finance Inc
21% Upside
CIM
Chimera Investment Corp
16% Upside
T
TMP
Tompkins Financial Corp
-3% Downside
TDOC
Teladoc Health Inc
-24% Downside
WHF
WhiteHorse Finance Inc
21% Upside
CIM
Chimera Investment Corp
16% Upside
T
TMP
Tompkins Financial Corp
-3% Downside

Revenue
Forecast

26% / Year
Past Growth
16% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss
26% / Year
Past Growth
16% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 26%. The projected CAGR for the next 8 years is 16%.

What are analyst estimates?

Gross Profit
Forecast

26% / Year
Past Growth
16% / Year
Estimated Growth
Estimates Accuracy
3%
Average Beat
26% / Year
Past Growth
16% / Year
Estimated Growth
Estimates Accuracy
3%
Average Beat

Over the last 13 years, the compound annual growth rate for Gross Profit has been 26%. The projected CAGR for the next 8 years is 16%.

What are analyst estimates?

Operating Income
Forecast

67% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat
67% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat

Over the last 13 years, the compound annual growth rate for Operating Income has been 67%. The projected CAGR for the next 8 years is 12%.

What are analyst estimates?

Pre-Tax Income
Forecast

48% / Year
Past Growth
29% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat
48% / Year
Past Growth
29% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 48%. The projected CAGR for the next 3 years is 29%.

What are analyst estimates?

Net Income
Forecast

38% / Year
Past Growth
13% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss
38% / Year
Past Growth
13% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss

Over the last 13 years, the compound annual growth rate for Net Income has been 38%. The projected CAGR for the next 8 years is 13%.

What are analyst estimates?

Continue PME Research

Summary
PME intrinsic value, competitors valuation, and company profile.
DCF Valuation
PME stock valuation using Discount Cash Flow valuation method.
Relative Valuation
PME stock valuation using valuation multiples.
Wall St Estimates
PME price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
PME stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other Pro Medicus Ltd listings:
OTC • USD
PMCUF
 F • EUR
PMC
 OTC • USD
PMDIY
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is PME's stock price target?
Price Target
193.26 AUD

According to Wall Street analysts, the average 1-year price target for PME is 193.26 AUD with a low forecast of 111.1 AUD and a high forecast of 257.25 AUD.

What is the Revenue forecast for Pro Medicus Ltd?
Projected CAGR
16%

Over the last 13 years, the compound annual growth rate for Revenue has been 26%. The projected CAGR for the next 8 years is 16%.

What is the Gross Profit forecast for Pro Medicus Ltd?
Projected CAGR
16%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 26%. The projected CAGR for the next 8 years is 16%.

What is the Operating Income forecast for Pro Medicus Ltd?
Projected CAGR
12%

Over the last 13 years, the compound annual growth rate for Operating Income has been 67%. The projected CAGR for the next 8 years is 12%.

What is the Pre-Tax Income forecast for Pro Medicus Ltd?
Projected CAGR
29%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 48%. The projected CAGR for the next 3 years is 29%.

What is the Net Income forecast for Pro Medicus Ltd?
Projected CAGR
13%

Over the last 13 years, the compound annual growth rate for Net Income has been 38%. The projected CAGR for the next 8 years is 13%.

Back to Top
ALPHA SPREAD
Follow us
Join 348,100+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

AI Assistant
Get AI-powered insights for any company or topic.
Open AI Assistant
Other Tools
Stock Screener
Discover stocks
Stock Comparison
Smarter decisions through side-by-side analysis
Intrinsic Value Calculator
Discover the true worth of your stocks
DCF Value Calculator
Harness the power of DCF

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett